Banking industry

Banking industry

Transkaryotic Therapies, Inc. to Present at Deutsche Bank Securities 29th Annual Healthcare Conference

Transkaryotic Therapies, Inc. is a biopharmaceutical company focused on researching and developing treatments for rare diseases caused by protein deficiencies. The company will participate in the Deutsche Bank Securities 29th Annual Healthcare Conference, presenting an overview of its business activities. This event will be an opportunity for investors and stakeholders